Trans therapy refers to a broad range of medical, psychological, and social interventions designed to help transgender and gender diverse people live in alignment with their gender identity. These interventions span from fully reversible steps like social transition and talk therapy to partially reversible hormone treatments and irreversible surgical procedures. The current international clinical framework, the Standards of Care Version 8 (SOC-8) published by the World Professional Association for Transgender Health, bases its recommendations on systematic literature reviews and expert consensus across 18 chapters of guidance for healthcare professionals.1PubMed Central. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 The landscape of trans-related healthcare is wide, and the evidence behind each intervention varies considerably in depth and quality.
Social Transition in Children and Adolescents
Social transition is the least medically invasive step and involves changes like adopting a new name, pronouns, hairstyle, or clothing to match a child’s gender identity. No hormones or procedures are involved. Research on prepubescent children who socially transitioned found that their rates of depression were comparable to those of matched peers and siblings, and their self-worth scores were similar as well. Anxiety was somewhat higher, with parents reporting more anxious symptoms in their transgender children than in control-group children.2PubMed Central. Mental Health and Self-Worth in Socially Transitioned Transgender Youth A follow-up study looking at parent-reported symptoms before and after social transition found that, on average, youth showed lower levels of internalizing problems after transitioning than before.3PubMed Central. A Study of Parent-Reported Internalizing Symptoms in Transgender Youth Before and After Childhood Social Transitions
These findings have been described in the pediatric literature as evidence that social transition is a completely reversible intervention associated with lower rates of depression and anxiety in transgender prepubescent children.4Pediatrics. Social Transition: Supporting Our Youngest Transgender Children The research base here is still relatively small, and the studies are observational rather than randomized, but the direction of the evidence is consistent: children who are supported in social transition tend to look psychologically similar to their non-transgender peers.
Puberty Blockers
For adolescents approaching or in early puberty, gonadotropin-releasing hormone (GnRH) agonists can pause pubertal development. The idea is to give young people more time to explore their gender identity before irreversible pubertal changes occur. This intervention has drawn intense scrutiny from both supporters and critics, and the evidence base is genuinely thin. A systematic review and meta-analysis examining puberty blockers for gender dysphoria in youth found that the available before-and-after studies provided very low certainty of evidence for outcomes including gender dysphoria itself, global functioning, depression, and bone mineral density.5Archives of Disease in Childhood. Puberty blockers for gender dysphoria in youth: A systematic review and meta-analysis
Government bodies in Finland, Sweden, the United Kingdom, and the U.S. state of Florida have all commissioned their own systematic reviews of the evidence for hormone treatments in youth and issued formal reports, leading to varying policy responses.6Human Systems: Therapy, Culture and Attachments. Evolving national guidelines for the treatment of children and adolescents with gender dysphoria: International perspectives Some of these reviews concluded that the evidence was insufficient to support routine use, while others maintained that the benefits of preventing unwanted pubertal development justified continued prescribing under careful oversight.
The most consistent concern with puberty blockers is their effect on bones. Research consistently shows that long-term puberty suppression reduces bone mineral density, particularly at the lumbar spine, and that the deficit is only partially restored once sex hormones are introduced. Adolescents assigned male at birth appear more vulnerable to this effect than those assigned female at birth.7PubMed Central. Impact of gender-affirming treatment on bone health in transgender and gender diverse youth A cohort study tracking bone density after long-term hormone therapy found that bone density scores generally caught up with pretreatment levels after hormones were started, except at the lumbar spine in those receiving estrogen, where the deficit persisted.8JAMA Pediatrics. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones This means that bone health monitoring is not optional for anyone on puberty blockers, and estrogen optimization and lifestyle counseling are especially important for those assigned male at birth.
Hormone Therapy for Adults
Gender-affirming hormone therapy is the medical backbone of transition for most adults. For trans women and transfeminine individuals, this means estrogen (often combined with an anti-androgen). For trans men and transmasculine individuals, it means testosterone. Both bring a set of desired physical changes alongside effects that need medical monitoring.
Estrogen Therapy
Estrogen promotes breast development, softens skin, redistributes body fat toward a more typically female pattern, and slows body hair growth. The most closely watched medical risk is blood clots. Trans women using estrogen face a higher risk of both arterial and venous thrombosis, and that risk may increase the longer someone is on estrogen.9PubMed. Thrombotic risk associated with gender-affirming hormone therapy A large cohort study found that transfeminine participants had a meaningfully higher incidence of venous thromboembolism compared to both cisgender men and cisgender women, while the overall rates of heart attack and ischemic stroke were similar across groups.10PubMed Central. Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study Lower-dose transdermal estrogen formulations (patches or gels) are generally preferred over high-dose oral pills because the oral route carries higher clotting risk.11PubMed. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review
Testosterone Therapy
Testosterone deepens the voice, increases body and facial hair growth, redistributes body fat, increases muscle mass, and often stops menstruation. Among the key monitoring concerns is erythrocytosis, where the body produces too many red blood cells. In a large cohort of trans men, about 11% developed elevated hematocrit levels, with the risk climbing over time: roughly 10% after one year and 38% after ten years. Tobacco use, higher body weight, older age at starting testosterone, and long-acting injectable formulations all increased the likelihood.12PubMed Central. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years
Testosterone also shifts cholesterol in an unfavorable direction. Multiple studies have found that it raises LDL (the “bad” cholesterol) and lowers HDL (the “good” cholesterol), along with modest increases in body mass index and hemoglobin.13PubMed. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review A more recent retrospective study confirmed the same pattern, with HDL dropping significantly and LDL and triglycerides both rising.14PubMed Central. A Retrospective Study in Trans Individuals Undergoing Gender Affirming Testosterone Treatment: Can Changes in Prolactin Counteract the Negative Effects on the Lipid Profile? These lipid changes have not yet translated into clear increases in heart attacks or strokes in trans men in the studies conducted so far, but they reinforce why regular blood work is a non-negotiable part of testosterone therapy.
Bone Health on Long-Term Hormones
For adults already past puberty, gender-affirming hormones generally maintain or even improve bone density in the short to medium term.15PubMed Central. Osteoporosis and Bone Health in Transgender Persons The picture shifts over longer time horizons. After gonadectomy (removal of the testes or ovaries) and about 15 years of hormone therapy, both trans women and trans men showed a significant decrease in total hip bone mineral density compared to their levels at 10 years.16The Journal of Sexual Medicine. Bone Mineral Density in Transgender Individuals After Gonadectomy and Long-Term Gender-Affirming Hormonal Treatment No differences in fracture rates have been documented in the shorter prospective trials that exist, but the downward trend in density after gonadectomy means that screening and preventive care for osteoporosis become increasingly relevant over a lifetime of hormone use.
Skin and Body Changes Beyond the Expected
Hormone therapy brings some dermatological effects that catch people off guard. Trans men on testosterone often develop acne, sometimes severe enough to need treatment, along with male pattern hair loss. Trans women on estrogen may experience persistent unwanted facial hair (a holdover from prior testosterone exposure), pseudofolliculitis barbae (ingrown hairs, often from shaving), and melasma, a type of skin darkening.17PubMed Central. Dermatologic Conditions in Transgender Populations
A multicenter prospective study found that the type of testosterone formulation matters for skin outcomes. Injectable testosterone esters produced a significantly higher increase in acne scores compared to testosterone gel, and also drove more facial hair growth. For trans women, estrogen reduced facial hair scores over time, but after 12 months more than half still had noticeable facial hair.18PubMed Central. Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI) This is why laser hair removal and electrolysis remain standard complements to estrogen for many trans women, and why managing acne expectations is important for trans men starting testosterone.
Surgical Interventions and Satisfaction
Gender-affirming surgeries range from chest procedures (mastectomy for trans men, breast augmentation for trans women) to genital reconstruction (vaginoplasty, phalloplasty, metoidioplasty) to facial feminization surgery. The data on satisfaction are, by surgical standards, remarkably positive. A meta-analysis pooling nearly 8,000 patients across 27 studies found that the overall rate of regret after any type of gender-affirming surgery was about 1%.19PubMed Central. Regret after Gender-affirmation Surgery: A Systematic Review and Meta-analysis of Prevalence A separate study specifically examining gender-affirming mastectomy found a median satisfaction score at the top of the scale and a median regret score of zero.20JAMA Surgery. Long-Term Regret and Satisfaction With Decision Following Gender-Affirming Mastectomy
A systematic review covering multiple surgery types reported that most patients were satisfied with their outcomes at least a year post-surgery, and that both psychological and sexual well-being were generally positive, though the quality of individual studies was often low, with small sample sizes and no comparison groups.21PubMed Central. Surgical satisfaction and quality of life outcomes reported by transgender men and women at least one year post gender-affirming surgery: A systematic literature review
Facial feminization surgery has emerged as particularly impactful for trans women. One study found that people who had undergone facial feminization reported significantly better scores for anxiety, depression, positive mood, sense of meaning and purpose, and social isolation compared to those who had not, even after accounting for other surgeries, duration of hormone therapy, and pre-existing mental health diagnoses.22PubMed. Effect of Gender-affirming Facial Feminization Surgery on Psychosocial Outcomes Another study measuring facial satisfaction found that overall satisfaction with facial appearance nearly doubled after the procedure, with the greatest gains in the jawline, nose, and forehead regions.23PubMed Central. Quantifying Facial Feminization Surgery’s Impact: Focus on Patient Facial Satisfaction Research comparing trans women who had surgery to those who had not found that those without any surgical intervention had significantly lower mental health-related quality of life compared to both the general female population and trans women who had undergone genital surgery, facial feminization, or both.24PubMed. Quality of life of individuals with and without facial feminization surgery or gender reassignment surgery
Voice and Communication Training
Testosterone lowers the voice for trans men, usually within the first year. For trans women, estrogen does not raise vocal pitch, so voice work requires either speech therapy, surgery, or both. A systematic review and meta-analysis of speech therapy for trans women found that the average gain in fundamental frequency was about 25 to 39 Hz depending on the measurement context, with both speech therapy and phonosurgery improving female voice perception and vocal satisfaction.25PubMed Central. A speech therapy for transgender women: an updated systematic review and meta-analysis A separate study following trans women through voice training and beyond found that gains were maintained at extended follow-up, and that satisfaction with voice continued to improve even after formal therapy ended.26PubMed. Patient Satisfaction and Acoustic Changes in Trans Women after Gender Affirming Voice Training Voice is one of those areas that matters enormously for daily comfort and social perception, yet it often gets overshadowed in discussions of trans healthcare by hormones and surgery.
Mental Health Outcomes
The relationship between gender-affirming care and mental health is the most politically charged aspect of this field, and the evidence does not lend itself to a single clean narrative. A study of transgender and nonbinary youth found that those who had started puberty blockers or gender-affirming hormones had roughly 60% lower odds of moderate to severe depression and about 73% lower odds of self-harm or suicidal thoughts compared to those who had not yet started, with no clear effect on anxiety.27JAMA Network Open. Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care A prospective cohort study of adults found that depression symptoms decreased significantly in the first months of hormone therapy, though anxiety did not change significantly.28PubMed. Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study
A contrasting data point comes from a study that found individuals who underwent gender-affirming surgery had substantially higher rates of suicide attempts compared to control groups, even after statistical matching for confounders.29PubMed Central. Risk of Suicide and Self-Harm Following Gender-Affirmation Surgery This finding is frequently cited by critics of surgical intervention, but it requires context. People who pursue surgery tend to have more severe gender distress and often a longer history of mental health challenges at baseline. An elevated post-surgical rate compared to the general population does not mean the surgery made things worse; it may mean that surgery alone does not erase the cumulative effects of minority stress, discrimination, and pre-existing conditions. The evidence is genuinely hard to interpret because there are no randomized controlled trials (and likely never will be), so every study has confounders baked in.
Detransition
Detransition refers to stopping or reversing some aspect of a gender transition, whether social, medical, surgical, or legal. It is important to distinguish detransition from regret. They overlap sometimes but are not the same thing. Someone may detransition temporarily because of workplace discrimination and later resume their transition when their circumstances change. An analysis of the U.S. Transgender Survey, one of the largest available datasets, found that about 13% of respondents who had pursued gender affirmation reported a history of detransition. Among those who detransitioned, about 83% cited at least one external reason, with pressure from family and societal stigma being the most common. Only about 16% cited internal factors like fluctuations in their sense of gender identity.30PubMed Central. Factors Leading to “Detransition” Among Transgender and Gender Diverse People in the United States: A Mixed-Methods Analysis
An earlier analysis of the same survey framed detransition slightly differently, finding that about 8% had detransitioned at some point, most of them only temporarily. The most common reasons were pressure from a parent, finding transition too hard, harassment or discrimination, and trouble getting a job. Rates were higher among trans women (about 11%) than trans men (about 4%).31PubMed Central. Detransition Among Transgender and Gender-Diverse People—An Increasing and Increasingly Complex Phenomenon The picture that emerges is that most detransition is driven by external pressures rather than a fundamental change of mind about gender identity, though the latter does happen and deserves respectful clinical attention.
Fertility Preservation
Both estrogen and testosterone affect fertility, and surgical removal of reproductive organs makes biological parenthood impossible without prior gamete storage. Despite this, fertility preservation is often discussed too late or not at all. Transgender patients have reported finding it difficult to use reproductive services, partly because providers often do not raise the topic and the systems in place were not designed with transgender people in mind.32PubMed Central. Fertility preservation options for transgender individuals A Swedish study from 2013 to 2018 found that fertility preservation was requested after legislation changed to allow it, with trans women using it more frequently than trans men. Prior hormonal treatment, whether someone had had surgery, and sexual orientation all influenced the decision. Actual use of stored gametes was low, but pregnancies with live births did occur, mainly among the partners of trans men.33Human Reproduction Open. Fertility preservation and fertility treatment in transgender adolescents and adults in a Swedish region, 2013–2018 Early, frank conversations about fertility before any medical steps are taken remain one of the most consistently recommended practices in transgender healthcare guidelines.
Ongoing Screening and Primary Care
Hormone therapy creates screening needs that do not fit neatly into the standard care protocols designed for cisgender men or women. Breast cancer screening for trans women is one example. Both the Fenway Health and UCSF guidelines use five years of estrogen therapy as a threshold, extrapolating from data on postmenopausal cisgender women showing increased breast cancer risk after five or more years of hormone replacement. Trans women who have been on feminizing hormones for at least five years are generally recommended to begin mammography screening at age 50, though the two guidelines differ on whether that should be annual or every two years.34Mayo Clinic Proceedings. Breast Cancer Screening in Transgender Patients: A Review of Current Guidelines The research specifically on breast cancer risk in trans women is still limited, so these recommendations rely heavily on analogy to cisgender women.
More broadly, transgender individuals face significant barriers to accessing routine healthcare. A survey of over 27,000 transgender adults found that trans women and trans men were more likely than nonbinary respondents to postpone healthcare because of fear of discrimination, and that they had experienced discrimination in healthcare settings at higher rates. Nonbinary respondents, meanwhile, were more likely to delay care because of cost.35PubMed Central. Health Care Access and Utilization by Transgender Populations: A United States Transgender Survey Study These access barriers mean that even when screening guidelines exist, they are often not followed, and routine monitoring of hormone levels, blood counts, and metabolic markers falls through the cracks.
What Neuroscience Adds
A question that comes up often is whether there is anything measurably different about the brains of transgender people. The honest answer is: sort of, but the findings are subtle and do not explain gender identity in any simple way. A study using a multivariate classifier to estimate where a brain falls on a male-to-female continuum found that the brains of trans women before hormone therapy fell between cisgender men and cisgender women, still closer to cisgender men but significantly different from both groups.36PubMed Central. Brain Sex in Transgender Women Is Shifted towards Gender Identity A mega-analysis from the ENIGMA consortium found that transgender individuals differed from cisgender individuals in brain volume and surface area, but the patterns varied by brain region and by what was being measured, with no single clean “male brain” or “female brain” signature.37PubMed. The Neuroanatomy of Transgender Identity: Mega-Analytic Findings From the ENIGMA Transgender Persons Working Group Research into brain network connectivity found that trans men, trans women, and cisgender women all showed reduced connectivity compared to cisgender men in certain brain networks, with no differences among the first three groups.38PubMed. Brain network interactions in transgender individuals with gender incongruence
None of this constitutes a diagnostic brain scan for being transgender, and researchers in the field are careful to say so. What the data do suggest is that gender identity is not purely a social or psychological phenomenon; it has some footprint in brain structure and function. But the overlap between groups is large, and the differences are statistical tendencies visible only at the group level, not individual predictions. The neuroscience is interesting, but it is years away from having clinical applications.
How the Diagnosis Has Evolved
The way medicine has classified transgender experience has shifted dramatically over the decades, and that history shapes how care is delivered today. The first appearance of a formal diagnosis was “transsexualism” in the DSM-III in 1980, which also introduced a childhood diagnosis. Over subsequent editions, the terminology, placement, and criteria were revised repeatedly, driven partly by new research and partly by social and political factors.39PubMed. Gender incongruence/gender dysphoria and its classification history The DSM-5, published in 2013, replaced “gender identity disorder” with “gender dysphoria,” a shift intended to emphasize the distress rather than the identity itself as the clinical problem. The World Health Organization’s ICD-11 went further, moving gender incongruence out of the mental disorders chapter entirely and into a chapter on conditions related to sexual health.40PubMed Central. How gender dysphoria and incongruence became medical diagnoses – a historical review These diagnostic shifts matter practically because they determine whether and how insurance covers transition-related care, and they shape how clinicians think about who they are treating and why.